Results 191 to 200 of about 72,920 (308)
Background and Purpose Chronic migraine (CM) is a highly disabling condition that remains suboptimally treated. Metabolic disturbances may trigger migraine chronification, whereas impaired endogenous pain inhibition contributes to CM development. Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs), used for type 2 diabetes and obesity, show efficacy ...
Katarina Sićović +6 more
wiley +1 more source
From neuropeptides to toxins: illuminating the origins of venom complexity in cone snails. [PDF]
Koch TL +12 more
europepmc +1 more source
Cofactors in Anaphylaxis: Insights From the European Anaphylaxis Registry
Forty‐nine per cent of reactions reported suspected cofactors (26% of children/adolescents, 59% of adults). Adjusted odds ratios for reaction severity increased with increasing number of suspected cofactors. Consistent effects for individual suspected cofactors were only observed for acute infections (children) and alcohol (adults with food‐induced ...
Margitta Worm +13 more
wiley +1 more source
Neural regulatory networks: challenges and opportunities in the treatment of psoriasis. [PDF]
Guo D +9 more
europepmc +1 more source
Red forehead dot syndrome: a case report and review of literature. [PDF]
Alesefir W.
europepmc +1 more source
Distinct GPCR phosphorylation barcodes and arrestin conformational states direct arrestin‐mediated signaling and trafficking. The graphical abstract depicts the structural diversity of GPCR–arrestin complexes by overlaying representative core‐engaged and tail‐engaged conformations.
Varsha Gupta +1 more
wiley +1 more source
Beyond Histamine: Mast Cell-Neuron Communication in Chronic Pruritic and Pain Disorders. [PDF]
Kagan T, Yosipovitch G.
europepmc +1 more source
Abstract Objectives/Background The introduction of calcitonin gene‐related peptide antagonists has transformed migraine care. Zavegepant, a third‐generation intranasal gepant, offers a nonoral treatment option for acute migraine. Although clinical trials support its efficacy and safety, real‐world data are limited.
Eric Dunn +5 more
wiley +1 more source
Neuroimmune crosstalk in cancer: emerging immunotherapeutic opportunities. [PDF]
Dong T +7 more
europepmc +1 more source

